Voit lisätä twiitteihisi sijainnin, esimerkiksi kaupungin tai tarkemman paikan, verkosta ja kolmannen osapuolen sovellusten kautta. Halutessasi voit poistaa twiittisi sijaintihistorian myöhemmin. Lue lisää
Ivermectin Cochrane review applies tight selection filters, e.g. eliminating 7 of the 10 RCTs with estimable mortality effect, and splits the rest in 2 subgroups (in/outpatients) to reach an unavoidable conclusion of inconclusiveness. Nice hatchet job. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/full …
The live French Ivermectin RCT meta-analysis allows to contextualize the loss of information from Cochrane's selection of 3 papers only. The Bayesian analysis confirms that the probability of positive treatment effect is nearly 100%.pic.twitter.com/7eJGAhf9sN
Stephanie Weibel war und ist auch weiterhin an der Erstellung der Leitlinie beteiligt, welche die Behandlungen für Covid-19 in Deutschland auch für Ivermectin festlegen. Die Interessenskonflikte zu dieser Gruppe hatte ich schon mal gezeigt...pic.twitter.com/JFoQYgjCGb
Weibel sehe ich in der Auflistung gar nicht?
The confidence intervals look so large that I thought these must be joking.
The review also seems to falsely claim that the Niaee study had ~30% PCR negative patients. It's likely that those patients never got a PCR test due to shortages. (The limitations section of the paper pretty much implies that those patients were never PCR tested.)
"Cochrane is delighted to announce that we have received a grant of USD $1.15 million from the Bill & Melinda Gates Foundation."
Twitter saattaa olla ruuhkautunut tai ongelma on muuten hetkellinen. Yritä uudelleen tai käy Twitterin tilasivulla saadaksesi lisätietoja.
